Introduction
The E2F transcription factors play a role in diverse biological functions such as cell proliferation, differentiation and apoptosis (Dyson, 1998; Ishida et al., 2001b; Nevins, 2001; Stevaux and Dyson, 2002) . The E2F family has seven members of which E2Fs 1-5 contain a transactivation domain and induce the transcription in association with their heteromericbinding partners, DP1 and DP2 (Slansky and Farnham, 1996; Johnson and Schneider-Broussard, 1998; de Bruin et al., 2003; Di Stefano et al., 2003) . The E2F family members are involved in transcriptional regulation of many cellular genes that are specifically required for S phase entry and DNA synthesis (Dyson, 1998; Nevins, 2001; Stevaux and Dyson, 2002) . Recent studies have suggested that about 7% of mammalian promoters may be regulated by E2Fs (Kel et al., 2001) . Computerassisted analysis, modified chromatin immunoprecipitation assays and microarray results show that the E2Fs regulate genes that are involved in differentiation, development, proliferation, DNA damage checkpoint, as well as factors involved in chromatin assembly/ condensation, chromosome segregation and the mitotic spindle checkpoint (Ishida et al., 2001a; Muller et al., 2001; Weinmann et al., 2001b; Ren et al., 2002) . In addition, E2F1 has also been implicated in apoptosis (Phillips and Vousden, 2001) ; for instance, E2F1 overexpression leads to the premature S phase entry in the serum-starved Rat-1 fibroblasts, resulting in apoptosis (Shan and Lee, 1994) . Overexpression of E2F1 also induces proapoptotic genes such as APAF1 and p73, which have E2F-binding sites in their promoter (Irwin et al., 2000; Moroni et al., 2001) . E2F1 knockout mice experiments also clearly support a role of E2F1 in apoptosis (Hunt et al., 1997) .
A variety of mechanisms are involved in regulating E2F-mediated transcriptional activity. The best-studied mechanism involves repression by the Rb family of tumor suppressor proteins (Dyson, 1998) . Rb physically interacts with E2Fs 1, 2 as well as 3 and recruits a variety of corepressors such as histone deacetylase 1 (HDAC1), CtBP as well as Brg1, a chromatin remodeling protein (Brehm et al., 1998 (Brehm et al., , 1999 Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . In addition, Rb has been found to recruit histone methyl transferases as well as DNA methyl transferases to repress E2F-mediated transcription (Robertson et al., 2000) . During normal cell cycle progression, sequential phosphorylation of Rb in the G1 phase by various cyclin-dependent kinases releases free, transcriptionally active E2F, facilitating the expression of genes necessary for S phase entry (Knudsen and Wang, 1996) . E2F1 activity could also be regulated by its modification such as acetylation or phosphorylation. Phosphorylation of E2F1 by cyclin A/Cdk2 leads to its inactivation in the S phase (Vandel and Kouzarides, 1999) . On the other hand, acetylation enhances its DNA-binding ability as well as protein halflife. This is true in particular for the free form of E2F1 (Martinez-Balbas et al., 2000) .
Metallothioneins (MTs) are ubiquitous low molecular weight (61-68 amino acids) cysteine-rich proteins that are expressed in all eucaryotes. There are four major isoforms, MT1, MT2, MT3 and MT4; of these MT1 and MT2 are expressed in all eucaryotes and highly conserved through evolution (Moffatt and Denizeau, 1997; Ghoshal et al., 2002b) . MT3 and MT4 are expressed exclusively in mammals primarily in glutaminergic neurons and stratified squamous epithelium, respectively . MT1 is further classified into several subisoforms in humans ). These protein family members remarkably lack aromatic amino acids and contain high cysteine residues arranged in C-X-C motifs that helps in forming metal-thiolate bonds, which facilitates binding of bivalent metal ions (Kojima and Hunziker, 1991; Moffatt and Denizeau, 1997) . However, mono and trivalent metal ions such as Pt, Ag, Cu, Sb and Bi have also been known to bind with MTs (reviewed in ). Owing to their high cysteine content and ability to bind with various heavy metals, several lines of evidence have attributed the function to this protein family in metal metabolism and detoxification (Kagi and Valee, 1960; Kagi, 1991; Michalska and Choo, 1993; Masters et al., 1994; Moffatt and Denizeau, 1997; Butler and Roesijadi, 2001 ). They could act as reservoir of important metals such as Zn and Cu and could help transferring these ions to cellular macromolecules and also protect them from highly reactive free radicals by scavenging reactive oxygen species Schwarz et al., 1995; Kang et al., 1997) . Animal studies have shown that the MT1-MT2 knockout mice are sensitive to change in dietary zinc content and are also very susceptible to toxic metals (Kelly et al., 1996) ; overexpression of MTs exert resistance to these conditions (Michalska and Choo, 1993; Masters et al., 1994) . In addition, MTs have potent antiapoptotic effects in many cell systems (Kondo et al., 1997; Levadoux-Martin et al., 2001) . hMT2A is the predominant family member expressed in normal humans cells; it has been shown to be overexpressed in drug-treated cancer cells and repressed in metastatic tumors (Zhang et al., 1997) . hMTs level has been found significantly reduced in human hepatocellular carcinomas compared to surrounding healthy tissues (Cai et al., 1998) . Interestingly, MTs alone or in concert with other factors have also been speculated to function as growth suppressor in some tumors (Majumder et al., 1999a; Ghoshal et al., 2002b) .
Metal-mediated induction of the MT1 promoter occurs through two metal response elements (MREs) in the mouse MT1 promoter Searle et al., 1985 Searle et al., , 1987 . The metal transcription factor, MTF, binds to these sites upon exposure to heavy metals like Zn or Cd; this also promotes its rapid nuclear translocation, facilitating the expression of the MT1 promoter (Westin and Schaffner, 1988; Smirnova et al., 2000; Lichtlen and Schaffner, 2001a, b) . Here, we report that VEGF induces the human metallothionein 1G (hMT1G) promoter by utilizing E2F-binding sites in a signal-dependent fashion independent of metalmediated MREs. It may be inferred, thus E2F could influence other cellular processes by affecting the expression of proteins like MTs, which play a role in cellular stress response (Ghoshal et al., 1998; . We believe this is the first demonstration of VEGF affecting a promoter by inducing the binding of E2Fs and this might contribute to the prosurvival and angiogenic functions of VEGF.
Results

VEGF alters gene expression pattern in human aortic endothelial cells (HAECs)
Since E2F transcription factors regulate a variety of cellular processes in response to specific signaling events, we wished to examine whether they respond to VEGF signaling as well. As a first step, we decided to examine whether any of the genes induced by VEGF stimulation of human aortic endothelial cells are E2F regulated. Towards this purpose, we carried out a microarray analysis of genes induced by VEGF stimulation of HAECs. HAECs grown in growth factor-supplemented EBM-2 medium with 5% serum were starved of serum and VEGF for 24 h. They were stimulated with VEGF for 8 h, and total RNA isolated from stimulated as well as starved samples and a microarray analysis was carried out on an Affymetrix U133A Array. We found that the expression of many genes were changed more than threefold upon VEGF stimulation; 17 known genes were upregulated, whereas 16 were downregulated. They are listed in Table 1 . Some of these genes have been observed to change in response to VEGF by other groups as well. Examples include angiopoietin 1 (Abe and Sato, 2001) , cyclin A (Favot et al., 2003) , PAI-2 (Abe and Sato, 2001) , PLA2 (Boccellino et al., 2002) , HMG1-C and heparin-binding EGF like growth factor (Abe and Sato, 2001) . As can be seen from Table 1 , many genes involved in cell cycle regulation, signal transduction as well as tumor progression were induced by VEGF. Interestingly, one of the genes induced by VEGF stimulation was metallothionein 1G; it was found to be upregulated 6.5-fold upon VEGF stimulation. Since there are no reports indicating that MTs are induced by VEGF, we explored the mechanisms mediating the observed induction.
hMT1G is induced by VEGF in aortic endothelial cells
The induction of hMT1G gene by VEGF was first verified by Northern blotting. The cDNA of hMT1G was cloned by RT-PCR and used to probe total RNA E2F-mediated regulation of human metallothonein 1G gene B Joshi et al from starved and VEGF-stimulated cells. As shown in Figure 1a , metallothionein 1G was found to be upregulated in VEGF-stimulated sample in agreement with the microarray data, while GAPDH message was unaltered. VEGF-mediated induction of metallothionein 1G protein was also checked by immunostaining. HAECs were grown in eight-well chamber slides and VEGF-starved or -stimulated cells were immunostained using a polyclonal antibody to metallothionein 1. As shown in Figure 1b , a significant induction of metallothionein 1G was observed in VEGF-stimulated cells. b-Tubulin, which was tested as control, remained unaltered. In order to verify whether only hMT1G expression was affected by VEGF, we performed semiquantitative RT-PCR using divergent sets of primers for hMT1G, hMT2A, hMT1E and b-Actin following the published protocol (Mididoddi et al., 1996) . Obtained products were verified on 2% agarose gel and identity confirmed by sequencing. As can be seen in Figure 1c and d, expression of hMT2A or control b-Actin did not change upon VEGF stimulation of HAEC cells; hMT1E was not expressed at all, whereas hMT1G was found significantly upregulated upon VEGF stimulation. This further corroborates the results obtained in microarray experiments, where only hMT1G was induced by VEGF. These data suggest that VEGF can selectively induce metallothionein 1G gene expression in HAECs.
hMT1G promoter is E2F responsive
We hypothesized that the upregulation of metallothionein 1G by VEGF could be E2F mediated, since E2Fs are involved in the expression of many genes expressed in response to growth factor stimulation (Dyson, 1998; Ishida et al., 2001b; Nevins, 2001) . Examination of the hMT1G promoter revealed the presence of several potential binding sites for E2F1, flanked by those for SP1 (Figure 2a ), as present in many promoters that are regulated by E2F. In order to test the functionality of the E2F-binding sites, a 1000 bp fragment corresponding to the hMT1G promoter region was cloned by PCR and placed before CAT gene (MT-CAT). Saos-2 osteosarcoma cells were transiently transfected with MT-CAT reporter, with or without 2 mg of an E2F1 expression vector. As shown in Figure 2b , MT-CAT vector alone shows only minimal CAT activity; however, E2F1 expression vector could induce a significant amount of CAT activity. This suggests that the hMT1G promoter is E2F responsive.
We generated deletion mutants of the promoter to identify the shortest active and E2F responsive fragment. Two deletion mutants that retained 452 bp and 132 bp of the promoter were prepared by PCR and cloned in to pCAT-Basic reporter vector and named MT(B)-CAT, and MT(A)-CAT respectively. Transient transfection experiments were performed in Saos-2 cells with and without pDCE2F1. Cells were harvested after 72 h of growth and subjected to CAT assay. As shown in Figure 2c , À452 bp fragment of hMT1G promoter was fully functional and responded to E2F1, while the À132 bp fragment showed only negligible E2F response. This fragment of the promoter still had some putative E2F binding sites; attempts to eliminate them completely were not successful, since they were overlapping in short clusters. Nevertheless, the -132 bp fragment showed only marginal E2F response.
We next examined whether the cloned hMT1G promoter could respond to VEGF stimulation. HAEC cells were transiently transfected with MT-CAT or the two deletion mutants; the cells were serum starved for 24 h after transfection. Following this, cells were VEGF stimulated for 48 h and subjected to CAT assay. As shown in Figure 3a , VEGF stimulation triggered metallothionein 1G promoter activity more than twofold. Further, the À452 bp fragment of the promoter showed full response to VEGF, while the À132 bp fragment was only minimally induced by VEGF. This pattern is similar to the induction observed upon 
E2F1 can bind to the hMT1G promoter in vitro
Since it appeared that the E2F-binding sites were necessary for VEGF to induce the hMT1G promoter, attempts were made to see whether E2F does indeed bind to this promoter. This was first examined by electrophoretic mobility shift assays (EMSAs). Towards this purpose, we cloned a 160 bp fragment corresponding to the indicated region on the hMT1G promoter ( Figure 3b ) as a probe. Extracts from U937 cells were used to test whether E2F bound to this probe; as shown in Figure 3c (right panels), we observed a binding pattern that is similar to those obtained with a 120 bp probe derived from adenovirus E2 promoter (left panel). The E2 probe has been used extensively to study the DNA-binding activity of E2Fs (Chellappan et al., 1991 (Chellappan et al., , 1992 Fusaro et al., 2002) . Further, addition of an E2F1 monoclonal antibody abolished the major bands binding to the MT1 probe, suggesting that E2F1 can bind to HAEC cells grown in eight-well chamber slide were starved for 24 h, stimulated with VEGF and subjected to immunostaining as described in Materials and methods. While VEGF stimulation led to an increase in the staining of metallothionein 1 protein, there was no significant change in the levels of b-tubulin, which was tested as control. Hoechst staining shows the nuclei of the cells. (c) Semiquantitative RT-PCR showing hMT1G induction upon VEGF treatment. Total cDNA from starved or VEGF-treated HAEC was subjected to PCR using divergent sets of primers for MT1G, MT2A and MT1E isoforms following the protocol described in Mididoddi et al. (1996) . NRT-No RT and NRC-No RNA are controls. hMT1G appears upregulated in VEGF-treated sample, whereas no changes were observed in MT2A or b-actin expression level. There was no expression of MT1E in starved or VEGF-treated cells. E2F-mediated regulation of human metallothonein 1G gene B Joshi et al this region of the hMT1G promoter. Similarly, anti-Rb antibody could affect the mobility of the E2F complexes; while an antibody to cytochrome c, which was used as the negative control, did not affect the complexes at all. We conclude from this experiment that E2F1 can bind to the hMT1G promoter in vitro efficiently. It was next examined whether E2F1 binds to the hMT1G promoter in vivo. A chromatin (c) An EMSA using U937 whole-cell extracts on a probe derived from adenovirus E2 promoter (left panel). The binding pattern is similar to that observed for the MT1 probe (right panel). E2F1 and Rb antibodies affect the gel-shift bands obtained with the MT1 probe; the binding pattern was not affected by the control cytochrome c antibody. (d) ChIP assays showing in vivo association of E2F1 with the hMT1G, but not with hMT1E or hMT2A promoters. ChIP assays were carried out on serum-starved or VEGF-stimulated HAECs following the protocol described in Weinmann et al. (2001a) and Fusaro et al. (2003) . VEGF stimulation induces the binding of E2F1 to the 160 bp hMT1G promoter region; no E2F1 was found associated with either hMT1E or hMT2A promoters. There was no E2F1 bound to the c-fos promoter, which was the control. (e) VEGF treatment mediates E2F1 acetylation. Starved or VEGF-treated lysates were subjected to immunoprecipitation with antiacetylated lysine polyclonal antibody and Western blotted for E2F1. E2F1 is found acetylated only in VEGF-stimulated cells, suggesting that VEGF mediates E2F1 acetylation E2F-mediated regulation of human metallothonein 1G gene B Joshi et al immunoprecipitation (ChIP) assay was utilized for this purpose. ChIP assay lysates were prepared from serumstarved and VEGF-stimulated HAECs and immunoprecipitated with a control antibody or an antibody to E2F1. The presence of a 160 bp hMT1G promoter fragment in the immuneprecipitate was examined by PCR. As shown in Figure 3d , there was no E2F1 associated with the hMT1G promoter in serum-starved cells; but upon VEGF stimulation, a significant amount of E2F1 could be found in association with the promoter. The promoter fragment could not be detected in an immunoprecipitation carried out with a control antibody; similarly, an unrelated promoter, c-fos, could not be found in the E2F1 immuneprecipitate, confirming the specificity of the experiment. These results suggest that E2F1 can indeed bind to the hMT1G promoter and this is a signal-dependent event.
ChIP assays were also performed for hMT1E and hMT2A promoter to test whether VEGF induces the binding of E2F1 specifically to the hMT1G promoter. Primers were designed from the promoters of these genes and assays were performed. As it can be seen in Figure 3d (lower panels), MT1E and MT2A did not appear to be occupied by E2F1 implying that the VEGF induces the binding of E2F1 to hMT1G promoter specifically, but not to the promoters of other MT family members. Controls do not show any bands, confirming the specificity of experiment.
Experiments were conducted to understand how VEGF stimulation enhanced the binding of E2F1 to the promoter. It is known that the modification of E2F1 by acetylation imparts stability to protein, increases its DNA-binding ability and enhances its potential activation (Martinez-Balbas et al., 2000) . To examine whether the acetylation status of E2F1 changes upon VEGF stimulation, lysates from starved or VEGF-induced HAECs lysates were immunoprecipitated with an antiacetylated lysine antibody. The immunoprecipitates were Western blotted to examine the presence of E2F1. As can be seen in Figure 3e , E2F1 was found in the acetylated lysine immunoprecipitated from the VEGF-stimulated cells, but not in the starved cells; this shows that E2F1 is acetylated upon VEGF stimulation and may be available to activate multiple promoters.
Signal-dependent association of E2Fs and Rb with metallothionein1G promoter in vivo
We next examined whether VEGF stimulation affected the binding of E2F and Rb family members to the hMT1G promoter. This appeared a possibility since the region carrying multiple E2F-binding sites was necessary for VEGF-mediated induction of the hMT1G promoter. In order to assess this, ChIP assays were carried out on serum-starved HAECs, or those stimulated with VEGF for 24 h. Immunoprecipitations were carried out using a control antibody or antibodies to E2Fs 1-5, as well as Rb, p107 and p130 and the presence of the endogenous 160 bp promoter fragment (Figure 4a ) was examined by PCR. The promoter fragment could not be detected in immunoprecipitations of E2Fs 1, 2 or 3 family members from starved cells, suggesting that these E2Fs are not associated with the promoter in the starved cells (Figure 4b ). In contrast, there was a significant amount of E2Fs 4 and 5 associated with the promoter; similarly, the promoter could be found in association with Rb, p107 and p130 as well. This raises the possibility that Rb family members are associating with the promoter with the help of E2Fs 4 and 5, leading to its repression. Interestingly, VEGF stimulation led to a robust binding of E2Fs 1, 2 and 3 to the hMT1G promoter; while the binding of E2Fs 4 and 5 was reduced. At the same time, VEGF stimulation led to the dissociation of Rb as well as p107 and p130 from the hMT1G promoter. The promoter fragment could not be detected in immunoprecipitations carried out with the control antibody, showing the specificity of the assay. Similarly, the c-fos promoter, which is not regulated by E2Fs or Rb could not be detected in any of the immunoprecipitations. Given these findings, we conclude that VEGF stimulation induces the binding of E2Fs 1, 2, 3, while dissociating Rb family members, leading to the expression of the hMT1G promoter.
VEGF stimulation leads to acetylation of histones in the hMT1G promoter region
Histone acetylation is known to correlate with transcriptional induction and Rb is known to repress transcription by recruiting histone deacetylases (Luo et al., 1998) . Hence, we examined whether the acetylation status of the hMT1G promoter changes upon VEGF stimulation. This was carried out by ChIP assays using antibodies against acetylated histone H3 (Benjamin and Jost, 2001; Chaya et al., 2001; Gui and Dean, 2001; Dey et al., 2003) , on lysates from starved or VEGF-stimulated HAECs. As shown in Figure 4c , the promoter fragment could not be detected in anti-Ac-H3 immuneprecipitate from the starved cells, suggesting that the promoter is inactive; but upon stimulation with VEGF, the promoter fragment could be detected in the anti-Ac-H3 immuneprecipitate, suggesting that the histones in the promoter region are acetylated correlating with transcriptional activation. Thus, it appears that the hMT1G promoter is occupied by Rb and it is in a deacetylated, transcriptionally inactive state in quiescent HAECs, but stimulation with VEGF leads to the dissociation of Rb, increased binding of E2Fs, as well as acetylation of the histones in the region, leading to transcriptional activation of this promoter.
The above result was verified by doing a ChIP assay using anti-histone deacetylase (HDAC1) antibody on starved, VEGF-or ZnSO 4 -treated HAEC lysates. As expected, HDAC1 was found to be recruited on hMT1G promoter in starved cells, correlating with the histones being deacetylated and transcriptionally inactive. In contrast, HDAC1 was not found to be associated with the hMT1G promoter in cells when treated with VEGF or ZnSO 4 (Figure 4d ). Controls do not show any bands confirming the specificity of experiment.
Stimulation with metals does not affect Rb and E2F binding to hMT1G promoter
The mammalian MT1 promoter is known to be induced robustly by metals like zinc and cadmium; since VEGF stimulation of cells led to the increased biding of E2Fs to the promoter while Rb was dissociated, we examined whether ZnSO 4 could bring about similar effects. HAECs were serum starved for 24 h and stimulated with 100 mM ZnSO 4 every 12 h for 48 h. A ChIP assay was performed using a control antibody as well as antibodies to E2F1 and Rb. As shown in Figure 4e , there was a significant amount of Rb associated with the hMT1G promoter; there was no detectable amount of E2F1 present, as found earlier. Stimulation with 100 mM ZnSO 4 did not lead to the dissociation of Rb from the promoter; similarly, there was no increased binding of E2F1, as seen with VEGF stimulation. This result shows that stimulation of cells with ZnSO 4 does not alter the binding of Rb and E2F1 to the hMT1G promoter. Thus, it appears that the changes induced by VEGF are signal specific and do not occur when the promoter is induced by other signals.
E2F1-mediated induction of hMT1G promoter is independent of MRE and hMTF
Induction of MT promoters by heavy metals, such as Zn and Cd, and also by oxidative stress (Jacob et al., 1999) occurs through the MREs (metal-regulatory elements) that are bound by hMTF (metal transcription factor) (reviewed in ). Since we found that VEGF stimulation led to the binding of E2F1, we decided to examine whether the induction of metallothionein 1G promoter by E2F is independent of hMTF and whether the response of this promoter to VEGF and metals are mediated through different transcription factor-binding sites. Towards this purpose, we generated an hMT1G promoter with both the MREs mutated by using overlap-extension PCR; the E2F-binding sites remained intact (Figure 5a ). The effect of the mutation on hMTF binding was tested in an EMSA.
35
S-labeled hMTF was prepared by in vitro transcription translation and was used in a gel shift reaction with a 160 bp fragment of the wild-type hMT1G promoter. In all, 100 mM ZnSO 4 was added to the reaction mixture to facilitate the binding of hMTF (Dalton et al., 1996 (Dalton et al., , 1997 Bittel et al., 1998; Larochelle et al., 2001) . As shown in Figure 5b , the in vitro translated hMTF1 could bind to the promoter efficiently; addition of 50 or 100 ng of cold wild-type 160 bp promoter fragment competed this binding effectively. In contrast, the same amounts of the 160 bp promoter fragment with the MREs mutated did not compete the binding. This shows that The E2F-binding sites remained intact on the promoter with the MRE sites mutated. We next examined whether inactivation of the MRE affects the binding of E2F to the promoter. This was tested by a ChIP assay. HAECs were transiently transfected with a CAT gene driven by the wild-type hMT1G promoter, or a promoter with the MRE sites mutated (MT (MÀ)). ChIP lysates prepared from serum-starved or VEGFstimulated cells were immunoprecipitated with a control antibody or an antibody to E2F1 and the presence of the transfected promoter was detected by PCR, using an upstream primer derived from the hMT1G promoter and a downstream primer from the CAT gene. As seen in Figure 5c , the promoter fragment could be detected in association with E2F1 in cells transfected with both the wild-type promoter as well as the promoter with the MRE sites mutated. The presence of c-Fos promoter was tested as a control; it could not be detected in association with E2F1 showing the specificity of the experiment. This experiment shows that mutation of the MRE sites does not affect the binding of E2F1 to the hMT1G promoter.
The effect of mutating the MRE on response of the promoter to hMTF1 and E2F1 was tested in a transient transfection experiment. Saos-2 cells were transiently transfected with a CAT reporter driven by the fulllength wild-type hMT1G promoter or one with the MRE sites mutated. As shown in Figure 5d , cotransfection of MTF1 or E2F1 could induce the wild-type promoter efficiently. In contrast, cotransfection of hMTF1 had only a minimal effect on the MRE mutated promoter; at the same time, this promoter could be induced significantly by E2F1, comparable to the wildtype promoter. This experiment suggests that the MRE mutant promoter cannot respond to hMTF1, but can respond efficiently to E2F1.
VEGF and metal response of hMT1G promoter are mediated through different sites
While it is well established that response of the MT promoter to heavy metals is mediated through the MREs, our results suggest that VEGF-directed induction of this promoter is mediated through E2F-binding sites. Experiments were designed to examine whether the hMT1G promoter uses these transcription factors in a signal specific fashion, or whether they can substitute for one another. Transient transfection experiments were carried out to examine this. Saos-2 cells were transfected with the hMT1G promoter-CAT reporter or the hMT1G-MRE mutant promoter CAT. Cotransfection of hMTF1, or stimulation with ZnSO 4 induced the wildtype promoter (Figure 6a ). In contrast, the MRE site mutant promoter did not respond to hMTF1 or ZnSO 4 , suggesting that the MRE sites are essential for metal response. We next examined whether deletion of the E2F sites affected the metal response. The full-length MT1-CAT construct, MT1-B CAT vector, which has the 452 bp of the promoter region, or the MT1-A CAT, which has the 132 bp region of the promoter driving the CAT gene were transfected into Saos-2 cells; stimulation with ZnSO 4 showed that all three constructs could mediate metal response very effectively (Figure 6b) . We had observed earlier that the MT1(A)-CAT construct had only a limited response to VEGF stimulation (Figure 3a) . This result suggests that the E2F sites in the hMT1G promoter are not necessary for mediating metal response. We next examined whether the hMT1G deletion constructs lacking the E2F sites could mediate metal response in serum-starved cells. Saos-2 cells were transfected with full-length MT1-CAT, MT1-(A) or MT1-(B) constructs. The cells were serum starved for 24 h following transfection; at this time, cells were treated with 100 mM of ZnSO 4 (every 12 h) and grown for additional 48 h. A CAT assay showed that ZnSO 4 could induce all three promoter constructs even when the cells were grown in a growthfactor-free medium (Figure 6c ). Since E2Fs are known to predominantly mediate growth factor response, this experiment confirms that the E2F-binding sites do not contribute to the metal response of the hMT1G promoter.
The role of the two metal response elements in responding to VEGF stimulation was next examined. HAECs were transiently transfected with the wild-type and MRE mutant MT1 reporters. After starvation for 24 h, cells were stimulated with VEGF for 48 h and CAT activity was measured. As shown in Figure 6d , VEGF stimulation led to the induction of both the reporters to a comparable extent. This result shows that the MRE sites are not necessary for the VEGF response. These experiments suggest that heavy metals and VEGF induce the hMT1G promoter through different sites using different transcription factors.
Discussion
VEGF is known to have proliferative, antiapoptotic and prosurvival functions, in addition to its well-established angiogenic functions. Studies from many labs suggest that VEGF mediates these functions to a certain extent by affecting the expression of various cellular genes. Our studies show that one of the genes induced by VEGF is metallothionein 1G gene. MT isofoms are known to have antiapoptotic functions that are involved in metal and stress response (Kondo et al., 1997; Levadoux-Martin et al., 2001) . In addition, we show that the VEGF-mediated induction occurs through E2F transcription factors, which are important mediators of growth factor response.
Many of the genes we found to be altered upon VEGF stimulation have been shown by other groups to be VEGF responsive; examples include angiopoietin-2, PAI-1 (Abe and Sato, 2001) , cyclin A (Favot et al., 2003) , podocalyxin-like protein, Down syndrome candidate region 1 and protein phosphatase 5 (Abe and Sato, 2001) . We focused on MT since its induction by VEGF had not been documented before and since it plays a vital role in promoting cell survival. It is possible that the prosurvival functions of VEGF are mediated at least in part by activating MTs or related genes. It is not clear whether metallothionein 1G plays a role in VEGFinduced angiogenesis.
Previous studies on the mouse MT1 promoter had shown that the metal response is mediated by the metal transcription factor, MTF1 Searle et al., 1985 Searle et al., , 1987 Lichtlen and Schaffner, 2001a, b) . In addition, other factors like STAT1 and STAT3 have been known to be involved in interferon-mediated induction of MT1 (Lee et al., 1999) . An examination of the hMT1G promoter showed that the consensus STAT-binding sites present on the mouse promoter are absent in humans. There were two potential sites that had some similarity, but no identity, to the consensus STAT sites. It remains to be seen whether these sites mediate the interferon response in human cells. Similarly, transcription factors like MLTF1/USF, SP1 as well as glucocorticoid receptors have been shown to induce MT1 promoter under various circumstances (Ghoshal et al., 1998 . Functional involvement of MTs in breast cancer (Friedline et al., 1998) , renal cell carcinoma (Nguyen et al., 2000) , kidney and associated tumors (Hellemans et al., 1999) , bladder cancer (Somji et al., 2001) , and their silencing in many other cancer cells have raised interesting questions pertaining to the molecular mechanisms that involve MTs in cancer and tumorogenicity. Our finding that VEGF can stimulate metallothionein 1G gene raises the possibility that this could be one mechanism by which MTs affects tumor growth.
Our results show for the first time that hMT1G is VEGF inducible and that hMT1G promoter is E2F responsive. The role of E2F seems to be specific for the VEGF response, since deletion of the E2F sites did not affect metal response of the hMT1G promoter. It is intriguing that E2Fs 1, 2 and 3 were not detected on the promoter in quiescent cells, but a significant amount of Rb, p107 and p130 were. E2Fs 1-3 are known to play the major transcription regulatory functions in proliferating cells; hence, it can be expected that a proliferative signal like VEGF led their binding to the hMT1G promoter. E2Fs 4 and 5 are thought to function mainly in quiescent and differentiated cells; thus, it is likely that they play a role in keeping the promoter inactive in the absence of proliferative signals. Given the fact that the histones in the promoter region were deacetylated in quiescent cells, we believe that the recruitment of HDAC1 by the Rb family members contributed to the repression in quiescent cells. Based on our results, we propose the model depicted in Figure 7 . hMT1G promoter in quiescent cells is occupied by E2Fs 4 and 5 as well as an excess amount of Rb family proteins (Figure 7a ). VEGF stimulation leads to the dissociation of Rb and enhanced recruitment of E2Fs 1-3, leading to E2F-mediated regulation of human metallothonein 1G gene B Joshi et al transcriptional activation (Figure 7b ). On the other hand, stimulation with heavy metals like ZnSO 4 leads to the active recruitment of hMTF and dissociation of HDAC1 from the promoter. Since Rb appears to remain on the promoter even after metal stimulation, it is likely that hMTF1 can over-ride the repressive effects of Rb by dissociating HDAC1 and probably recruiting coactivators like histone acetyl transferases, leading to promoter activation (Figure 7c) . Thus, the hMT1G promoter utilizes different transcription factor-binding sites to respond to different extracellular stimuli.
The induction of the binding of E2Fs to the promoter upon VEGF stimulation of quiescent cells with the concomitant dissociation of Rb is reminiscent of the changes taking place on proliferative promoters during cell cycle progression. This is interesting since not much is known about the role of metallothionein 1G in cell proliferation, or whether it is a cell-cycle-regulated gene. The finding that induction of hMT1G correlates with the acetylation of histones in the promoter region shows that histone acetyl transferases play a role in the induction of this promoter; similarly, HDAC1 is playing a role in keeping this promoter repressed. Recruitment of HDACs is a common mechanism by which Rb represses gene expression (Luo et al., 1998 ) and this appears to be true in the case of the hMT1G promoter in quiescent cells. Elegant studies from the Jacob lab have clearly established a role for DNA methylation in the repression of the MT1 promoter in the mouse system (Majumder et al., 1999a (Majumder et al., , b, 2002 Ghoshal et al., 2000 Ghoshal et al., , 2002a . It is possible that mechanisms like DNA or histone methylation also play a role in the regulation of the hMT1G promoter as well.
We believe the finding that hMT1G is responsive to E2Fs upon VEGF stimulation raises the possibility that signals that activate E2Fs may be inducing specific MT genes in different contexts and that these genes may contribute to functions other than metal and stress response. Given the proposed role of MT1 genes in human cancer, it is tempting to speculate that VEGFmediated induction of hMT1G might be contributing to the process of angiogenesis and tumor progression. This possibility, if true, might be an avenue that could be exploited for therapeutic intervention of tumor progression.
Materials and methods
Cell lines and whole-cell extracts
Osteosarcoma cell line Saos-2 was grown in DMEM media supplemented with 10% FBS. U937 cell line was grown in RPMI media supplemented with 10% FBS. HAECs were obtained from Clonetics, CA, USA and grown in EBM-2 medium supplemented with the growth factors and 5% FBS. For VEGF stimulation experiments, HAECs were rendered quiescent by growing in EBM-2 containing 0.5% FBS for 24 h; they were stimulated with 100 ng/ml of VEGF for the required periods of time. U937 cells or HAEC cells were collected by centrifugation at 1500 g for 10 min and the pellets were washed three times with cold PBS buffer. Whole-cell extracts were prepared by hypotonic shock followed by high salt extraction as described before (Fusaro et al., 2002) .
RNA isolation, microarray, RT-PCR, semiquantitative RT-PCR and Northern blotting HAEC cells grown as described above were subjected to serum starvation for 24 h, and stimulated with 100 ng/ml VEGF for 8 h. Unstimulated cells were used as control. Total RNA was isolated by RNAEasy mini-prep kit from Qiagen following the manufacturer's protocol. RNA quality and integrity was tested on formaldehyde gels prior to Microarray analysis. Affymetrix U133A microarray chips that carries about 12 000 human genes were used for assessing gene regulation patterns.
In order to verify the results obtained by microarray analysis, hMT1G gene was cloned by RT-PCR using AMV-RT kit (Promega). Total cDNA was then subjected to PCR, using forward and reverse primers designed for metallothionein 1G ( CCG CTC GAG TCA CTT GGA GAA G 3 0 ), TA-cloned and used for probe preparation. hMT1G and GAPDH probes were radiolabeled with a 32 P-dATP, a 32 P-dCTP using Prime-Gene labeling kit (Promega) following the manufacturer's protocols. To perform Northern blotting, 10 mg of total RNA was denatured, separated on formaldehyde agarose gel, capillary blotted on Zeta-probe charged nylon membrane (Bio-Rad), UV crosslinked and subjected to prehybridization and hybridization following the manufacturer's protocol. Signals were visualized by autoradiography. In order to assess the expression of various selected MT isoforms (hMT2A, hMT1G, hMT1E and b-actin as control), semiquantitative RT-PCR was performed using sets of divergent primers and protocol, and quantified as described in Mididoddi et al. (1996) .
Immunostaining and IP-Western
HAECs were plated on poly-D-lysine (Sigma)-coated eightwell glass chamber slides (15 000 cells per well) and allowed to grow overnight in EBM-2 medium as described before. Cells were subjected to serum starvation by growing in 0.5% serum for 24 h. Cells were then VEGF stimulated for 24 h followed by fixation in 3.5% paraformaldehyde for 25 min. They were then permeabilized in 0.2% Triton-X 100/PBS for 5 min and subjected to immunostaining using anti-MT1 polyclonal antibodies (1 : 250 dilution; Santacruz, CA, USA) as described before (Fusaro et al., 2003) . Anti-tubulin monoclonal antibody was obtained from Sigma and used at a dilution of 1 : 2000. Alexa-Fluor 488-conjugated goat anti-mouse IgG was used to visualize tubulin staining; similarly, Alexa-fluor 546-conjugated secondary antibody was used to visualize MT1 staining. Nuclear staining was performed with Hoechst dye at a final concentration of 0.0025 mg/ml. Cells were visualized with a Leica SenSys upright fluorescence microscope (Photometrics, Tuscon, AZ, USA).
In order to test the E2F1 acetylation, immunoprecipitation was carried out with starved or VEGF-stimulated lysates (250 mg each) using antiacetylated lysine protein polyclonal antibody (Santacruz, CA,USA) and Western blotted for E2F1 using monoclonal antibody. IP-Western was performed as described before (Fusaro et al., 2003) .
Plasmids and generation of mutants
The expression vector pDCE2F1 has been described earlier (Wang et al., 1999) . hMTF1 (metal transcription factor-1) expressing vector was a kind gift from Dr Ed Seto (Moffitt Cancer Center and Research Institute, Tampa, FL, USA). In order to prepare MT-CAT, a 1000 bp metallothionein 1G promoter was cloned by PCR using a forward primer carrying Mlu I (5 0 ACG CGT AGG ATT CAC ACC AAG CAG 3 0 ) and a reverse primer carrying Xho I site (5 0 CTC GAG CCC AAC AGC CA 3 0 ). The TA-cloned PCR product was subcloned into pCAT-Basic vector (Promega) to generate MT-CAT reporter for use in transient transfection experiments. In order to prepare deletion mutants, forward primers (5 0 CGA CGC GTA AAG TGG AGC ACA A 3 0 and 5 0 CGA CGC GTA TCT CCT GCG CAC A 3 0 ) annealing at À452 bp (MT(B)-CAT) and À132 bp (MT(A)-CAT) were designed. PCR products were TA-cloned and subsequently subcloned into pCAT-Basic vector for transient transfection experiments.
Two hMTF-binding sites (MREs) in hMT1G promoter were mutated by site-directed mutagenesis by an overlapping extension strategy using appropriate forward-reverse primers (5 0 CAG CTG CGC TCA AGG GAC CTT TCA TTT GCG CCA T 3 0 , 5 0 GCG TCT TCG CCG GGA TCC GTC 3 0 , 5 0 GAC GGA TCC CGG CGA AGA CGC 3 0 ) and MT-CAT as a template. The PCR product was TA-Cloned and called TA-MT1 (MRE mut). Subsequently, the mutant fragment was used as a primer to generate a full-length mutant hMT1G promoter. This fragment was cloned into pCAT-Basic to create MT (M)-CAT for use in transient transfection experiments.
Transient transfections
Transient transfections of 1 Â 10 7 Saos-2 and HAECs were performed by electroporation using a Bio-Rad Gene Pulser at 250 and 200 mV constant current, respectively; 4 mg of the reporters were used. To assess the metal response of transfected MT-CAT or MT(M)-CAT, cells were grown in complete medium supplemented with 100 mM ZnSO 4 /ml for 48 h (supplied with fresh dosage every 12 h) prior to CAT assay.
As an internal control for transfection efficiency, 2 mg b-galctosidase-expressing plasmid was used. Assays for bgalactosidase and chloramphenicol acetyl transferase (CAT) activity were performed 72 h after transfection using standard protocols. Experiments were repeated multiple times and results from two representative experiments are shown.
ChIP assays
ChIP assays were carried out as described previously (Weinmann et al., 2001a; Fusaro et al., 2003) . To test the interaction between E2F1 and hMT1G promoter, Saos-2 cells were transiently transfected with 4 mg of MT-CAT and MT-CAT plus 2 mg of pDC-E2F1. Endogenous E2F1-MT promoter interaction upon VEGF stimulation was tested in HAEC cells. After appropriate incubations, cells were treated with 1% formaldehyde for 10 min at room temperature in order to crosslink protein-DNA complexes. Cells were harvested, washed three times in 1 Â PBS, and lysed in a SDS, 50 mM Tris-HCI (pH 8.1) and 1 mM EDTA. Cells were the sonicated two times at 10 W for 15 s, cell debris pelleted at 41C, and the supernatant evenly distributed for incubation with primary antibodies. One aliquot of the supernatant was reserved to serve as the input reaction. Reactions were performed in a final volume of 400 ml in dilution buffer (0.01% SDS, 16.7 mM Tris-HCI (pH 8.1), 1.2 mM EDTA, 150 mM NaCl and 1% Triton-X 100) plus 3 mg of the appropriate primary antibody and rotated overnight at 41C. Antibodies to E2Fs 1-5 as well as Rb, p107, p130 and HDAC1 were purchased from Santa Cruz Biotechnologies, antiacetylated-histone H3 monoclonal antibody was purchased from Upstate Biotechnology (Benjamin and Jost, 2001; Chaya et al., 2001; Gui and Dean, 2001; Dey et al., 2003) and secondary anti-mouse antibody was purchased from Pierce. Then, 400 ml of Protein A Sepharose beads (30 mg/ml in dilution buffer) was added to each reaction and rotated for 2 h at 41C. Beads were washed three times in dilution buffer, followed by one additional wash in dilution buffer containing 500 mM NaCl, incubated with 300 ml elution buffer (1% SDS, 0.1 M Na 2 CO 3 ) and rotated for 20 min at room temperature. Eluted supernatants as well as input DNA samples were then decrosslinked by incubating at 651C for 4 h. DNA was then ethanol precipitated, and treated with Proteinase-K for 30 min at 371C. The samples were then extracted in phenol : chloroform, ethanol precipitated, and resuspended in 20 ml PCRgrade water (Sigma). PCR reactions were then performed using 5 ml of the DNA from the IP reactions or 1 ml of DNA from the input reaction as template. In vivo hMT1-G promoter occupancy by E2F after MRE sites mutation was tested by using hMT1-G forward and CAT2R primers. HAEC cells were transiently transfected with MT-CAT and MT(M)-CAT.
A set of cells was serum starved and a set of cells was VEGF stimulated. ChIP lysates were prepared and assay was performed. Fos promoter was used as a negative control in order to test the specificity of all ChIP assays and PCR reactions with immunoprecipitates were carried out using Fos promoter primers. The sequences of the primers used in the PCR reactions were as follows:
hMT-I G promoter (forward primer) 5 0 TGC GCT CAA GGG ACC TTG CA 3 
EMSAs
An EcoRI fragment of the (160 bp) hMT1G promoter containing putative E2F-binding sites was end labeled with a 32 P-dATP by Klenow enzyme (Promega) and used as the wild-type probe (Fusaro et al., 2002) . Whole-cell extract (6 mg) from U937 cells was incubated with 0.2 ng of labeled Wt-Probe in a buffer containing 20 mM HEPES, pH 7.9, 40 mM KCl, 1 mM MgCl 2 , 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 1 mM NaF, 1 mM Na 3 VO 4 , 0.5% NP-40, 1.5 mg/ml of salmon sperm DNA and 10 mg/ml of BSA. After incubating at room temperature for 15 min, the reactions were separated on a 4% polyacrylamide gel in 0.25% TBE buffer at 300 V for 2.5 h at 41C (Wang et al., 1999; Fusaro et al., 2002 Fusaro et al., , 2003 . The gels were then dried and the bands were visualized by autoradiography. For super shift assays, the extracts were first preincubated with 4 ml (0.8-1 mg) of antibody in 1 Â shift buffer prior to DNA binding. All antibodies used in the EMSAs were purchased from Santa Cruz Biotechnologies.
EMSAs were also performed with the probe that carried mutated MRE sites. TA-MT1 (MRE-mut) vector was digested with EcoRI and the fragment was end labeled and used in reactions as described above.
35
S-labeled hMTF was synthesized in vitro by transcription translation and used for EMSAs using Wt-Probe as well as Mut-Probe; 100 mM ZnSO 4 was added to the reaction mixture to enhance the binding (Dalton et al., 1996 (Dalton et al., , 1997 Bittel et al., 1998; Larochelle et al., 2001) . For the competition assays, cold Wt-160 bp and Mut-160 bp fragments were added to the reaction mixtures with end-labeled Wt-Probe and 35 S-labeled hMTF. Reactions were carried out in presence of 100 mM ZnSO 4 and binding was assessed as described above. Signals were visualized by autoradiography.
